Literature DB >> 33737539

Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.

Ravneet Chhabra1, Stephanie Rockfield1,2, Jennifer Guergues1,3, Owen W Nadeau3, Robert Hill1, Stanley M Stevens1,3, Meera Nanjundan4.   

Abstract

Malignant transformation of fallopian tube secretory epithelial cells (FTSECs) is a key contributing event to the development of high-grade serous ovarian carcinoma (HGSOC). Our recent findings implicate oncogenic transformative events in chronic iron-exposed FTSECs, including increased expression of oncogenic mediators, increased telomerase transcripts, and increased growth/migratory potential. Herein, we extend these studies by implementing an integrated transcriptomic and mass spectrometry-based proteomics approach to identify global miRNA and protein alterations, for which we also investigate a subset of these targets to iron-induced functional alterations. Proteomic analysis identified > 4500 proteins, of which 243 targets were differentially expressed. Sixty-five differentially expressed miRNAs were identified, of which 35 were associated with the "top" proteomic molecules (> fourfold change) identified by Ingenuity Pathway Analysis. Twenty of these 35 miRNAs are at the 14q32 locus (encoding a cluster of 54 miRNAs) with potential to be regulated by DNA methylation and histone deacetylation. At 14q32, miR-432-5p and miR-127-3p were ~ 100-fold downregulated whereas miR-138-5p was 16-fold downregulated at 3p21 in chronic iron-exposed FTSECs. Combinatorial treatment with methyltransferase and deacetylation inhibitors reversed expression of these miRNAs, suggesting chronic iron exposure alters miRNA expression via epigenetic alterations. In addition, PAX8, an important target in HGSOC and a potential miRNA target (from IPA) was epigenetically deregulated in iron-exposed FTSECs. However, both PAX8 and ALDH1A2 (another IPA-predicted target) were experimentally identified to be independently regulated by these miRNAs although TERT RNA was partially regulated by miR-138-5p. Interestingly, overexpression of miR-432-5p diminished cell numbers induced by long-term iron exposure in FTSECs. Collectively, our global profiling approaches uncovered patterns of miRNA and proteomic alterations that may be regulated by genome-wide epigenetic alterations and contribute to functional alterations induced by chronic iron exposure in FTSECs. This study may provide a platform to identify future biomarkers for early ovarian cancer detection and new targets for therapy.

Entities:  

Year:  2021        PMID: 33737539     DOI: 10.1038/s41598-021-85342-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  127 in total

1.  Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12.

Authors:  Shau-Ping Lin; Neil Youngson; Shuji Takada; Hervé Seitz; Wolf Reik; Martina Paulsen; Jerome Cavaille; Anne C Ferguson-Smith
Journal:  Nat Genet       Date:  2003-08-24       Impact factor: 38.330

2.  Proteomic Profiling of Iron-Treated Ovarian Cells Identifies AKT Activation that Modulates the CLEAR Network.

Authors:  Stephanie Rockfield; Jennifer Guergues; Nabila Rehman; Aaron Smith; Kyle A Bauckman; Stanley M Stevens; Meera Nanjundan
Journal:  Proteomics       Date:  2018-10-30       Impact factor: 3.984

Review 3.  The role of iron in tumour cell proliferation.

Authors:  Juan Luis Steegmann-Olmedillas
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

Review 4.  Ferroptosis: Death by Lipid Peroxidation.

Authors:  Wan Seok Yang; Brent R Stockwell
Journal:  Trends Cell Biol       Date:  2015-12-02       Impact factor: 20.808

Review 5.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

6.  Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Authors:  Liron Zehavi; Roi Avraham; Aviv Barzilai; Dalia Bar-Ilan; Roy Navon; Yechezkel Sidi; Dror Avni; Raya Leibowitz-Amit
Journal:  Mol Cancer       Date:  2012-07-02       Impact factor: 27.401

7.  14q32-encoded microRNAs mediate an oligometastatic phenotype.

Authors:  Abhineet Uppal; Sean C Wightman; Stephen Mallon; Go Oshima; Sean P Pitroda; Qingbei Zhang; Xiaona Huang; Thomas E Darga; Lei Huang; Jorge Andrade; Huiping Liu; Mark K Ferguson; Geoffrey L Greene; Mitchell C Posner; Samuel Hellman; Nikolai N Khodarev; Ralph R Weichselbaum
Journal:  Oncotarget       Date:  2015-02-28

8.  High grade serous ovarian carcinomas originate in the fallopian tube.

Authors:  S Intidhar Labidi-Galy; Eniko Papp; Dorothy Hallberg; Noushin Niknafs; Vilmos Adleff; Michael Noe; Rohit Bhattacharya; Marian Novak; Siân Jones; Jillian Phallen; Carolyn A Hruban; Michelle S Hirsch; Douglas I Lin; Lauren Schwartz; Cecile L Maire; Jean-Christophe Tille; Michaela Bowden; Ayse Ayhan; Laura D Wood; Robert B Scharpf; Robert Kurman; Tian-Li Wang; Ie-Ming Shih; Rachel Karchin; Ronny Drapkin; Victor E Velculescu
Journal:  Nat Commun       Date:  2017-10-23       Impact factor: 14.919

9.  Iron modulates cell survival in a Ras- and MAPK-dependent manner in ovarian cells.

Authors:  K A Bauckman; E Haller; I Flores; M Nanjundan
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 8.469

10.  Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models.

Authors:  Rachid Skouta; Scott J Dixon; Jianlin Wang; Denise E Dunn; Marina Orman; Kenichi Shimada; Paul A Rosenberg; Donald C Lo; Joel M Weinberg; Andreas Linkermann; Brent R Stockwell
Journal:  J Am Chem Soc       Date:  2014-03-14       Impact factor: 15.419

View more
  1 in total

1.  Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis.

Authors:  Hua-Xi Zou; Bai-Quan Qiu; Song-Qing Lai; Xue-Liang Zhou; Cheng-Wu Gong; Li-Jun Wang; Ming-Ming Yuan; An-Di He; Ji-Chun Liu; Huang Huang
Journal:  Biomed Res Int       Date:  2021-10-22       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.